Abstract

ECOPHARMACOVIGILANCE: AN OVERVIEW

Anamika Jaiswal*, Pooja Paul and Sudha Sah

Abstract

By means of developing years of technological advances, newer and more efficient drugs are being manufactured and are used on an ever growing scale for people with medical conditions. Ecopharmacovigilance is the science and activities associated with monitoring, detection, assessment, understanding and prevention of any obnoxious adverse reactions to pharmaceuticals at therapeutic concentration on animal and human beings. Disposal practices utilized by consumers and players in the pharmaceutical value in dealing with unused and expired products contribute to having pharmaceuticals and personal care products (PPCPs) in water sources and other environmental. And it has given a birth to the science of Ecopharmacovigilance. It aims to ensure that significant environmental issues associated with pharmaceuticals in the environment are identified in a timely way, and managed appropriately. The adverse effect of medicinal wastes on environment is yet to be understood in detail and addressed seriously in globe, since India stands as one of the country with highest pharmaceutical activity. The greatest challenge in EPV is of signal detection in environment and establishment of cause and effect. There should be laws and regulations on EPV, rational medication, drug take back programmers, policy guided and scientific researches on EPV by pharmaceutical firms and academia. this article generally focus is on what EPV means in clinical practice and there what practical measures can be taken to assess environmental risks across product life cycle, particularly after launch of new drug, to ensure that our risk assessment and understanding of pharmaceuticals in the environment remain scientifically and ecologically relevant.

Keywords: Ecopharmacovigilance, Policy, European Union, Environmental Risk Assessment, Indian Scenario.